Key result
The incidence of stent thrombosis following sirolimus-eluting stent implantation was notably lower in the Japanese J-Cypher registry compared to European cohorts.
Why the study?
Does Sirolimus-Eluting Stent (SES) compared to Bare Metal Stent (BMS) affect target lesion revascularization and stent thrombosis rates in Japanese patients undergoing PCI?
Does Sirolimus-Eluting Stent (SES) compared to Bare Metal Stent (BMS) affect target lesion revascularization and stent thrombosis rates in Japanese patients undergoing PCI?
Answers are grounded in this paper and cite their sources.
In a large Japanese registry, SES significantly reduced target lesion revascularization compared to BMS at 1 year, but was associated with a continuous low risk of very late stent thrombosis, emphasizing the need for careful management of antiplatelet therapy.
2006 11 37 Pci 29,555 Ses
No takes yet. Share an insight, caveat, or question.
木村 剛 (2009) conducted a review in Coronary artery disease (undergoing PCI). Sirolimus-Eluting Stent (SES) and antiplatelet therapy vs. Bare Metal Stent (BMS) / Western cohorts was evaluated on Stent thrombosis and Target Lesion Revascularization (TLR). The incidence of stent thrombosis following sirolimus-eluting stent implantation was notably lower in the Japanese J-Cypher registry compared to European cohorts.
Synapse has enriched 10 related papers. Consider them for comparative context: